Utama › Penyakit Paru Interstisial › Illinois › Chicago
Kajian klinikal Penyakit Paru Interstisial di Chicago, IL
12 kajian untuk Penyakit Paru Interstisial sedang mencari peserta di lokasi dalam dan sekitar Chicago (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Pulmonary Fibrosis Foundation Community Registry
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Pulmonary Fibrosis Foundation, Chicago
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Mengambil pesertaFasa 2/3
- GSK Investigational Site, Chicago
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Mengambil peserta
- Northwestern University, Chicago
- University of Illinois Health, Chicago
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
Mengambil pesertaFasa 3
- Northwestern University, Chicago
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Mengambil pesertaFasa 2
- Clinical Research Site, Chicago
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Mengambil pesertaKajian pemerhatian
- Northwestern University, Chicago
Platform Clinical Study for Conquering Scleroderma
Mengambil pesertaFasa 2
- The University of Chicago Medical Center (UCMC), Chicago
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Mengambil pesertaFasa 2/3
- Northwestern Memorial Hospital, Chicago
- The University of Chicago Medical Center, Chicago
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Mengambil pesertaKajian pemerhatian
- University of Chicago, Chicago
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Mengambil pesertaFasa 3
- Northwestern Memorial Hospital, Clinical Research Unit, Chicago
- Rush University Medical Center Outpatient Pulmonary Clinic, Chicago
- UI Health Hospital, Chicago
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- University of Chicago, Chicago
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Mengambil pesertaFasa 2
- aTyr Investigative Site, Chicago
- aTyr Investigative Site, Chicago
- aTyr Investigative Site, Chicago
Kajian Penyakit Paru Interstisial di bandar lain
- New York City, NY18 kajian
- Philadelphia, PA16 kajian
- Los Angeles, CA14 kajian
- Kansas City, KS13 kajian
- Durham, NC13 kajian
- Charleston, SC13 kajian
- Houston, TX12 kajian
- Ann Arbor, MI11 kajian
- Aurora, CO11 kajian
- Phoenix, AZ9 kajian
- Salt Lake City, UT9 kajian
- Boston, MA9 kajian
Kajian lain di Chicago
- Kanser Paru-paru Bukan Sel Kecil61 kajian
- Kanser Payudara58 kajian
- Kanser (semua jenis)51 kajian
- Kanser Metastatik45 kajian
- Kanser Prostat45 kajian
- Obesiti41 kajian
- Kanser Paru-paru41 kajian
- Kanser Ovari36 kajian
- Strok34 kajian
- Kanser Kolorektal33 kajian
- Kegagalan Jantung31 kajian
- Berat Badan Berlebihan28 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.